Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127166571 | 12716657 | 1 | I | 20160831 | 0 | 20160906 | 20160906 | DIR | US-FDA-349611 | FDA-CTU | 71.00 | YR | M | N | 61.00000 | KG | 20160902 | N | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127166571 | 12716657 | 1 | PS | cefazolin | CEFAZOLIN | 1 | Intravenous drip | OTHER STRENGTH:;OTHER DOSE:;OTHER FREQUENCY:ONCE;OTHER ROUTE: | Y | D | 0 | 2 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127166571 | 12716657 | 1 | Preoperative care |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127166571 | 12716657 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127166571 | 12716657 | Dyspnoea | |
| 127166571 | 12716657 | Generalised erythema | |
| 127166571 | 12716657 | Nausea | |
| 127166571 | 12716657 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127166571 | 12716657 | 1 | 20160831 | 20160831 | 0 |